Company press releases

Displaying 201 - 227 of 227 results
Released Company Title Industry Topic
05 Jan 2022
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies annonce d’excellentes performances de détection (CADe1) de nodules pulmonaires pour iBiopsy® Lung Cancer Screening 10101015 Software New
04 Jan 2022
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies : Calendrier de communication financière du premier semestre 2022 10101015 Software Meetings / events
04 Jan 2022
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies: Financial Communications Schedule for the First Half of 2022 10101015 Software Meetings / events
06 Dec 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 novembre 2021 10101015 Software Legal
06 Dec 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2021 10101015 Software Legal
23 Nov 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies annonce de nouvelles performances exceptionnelles pour le diagnostic iBiopsy® (CADx1) LCS portant spécifiquement sur la caractérisation du cancer pulmonaire de stade 1 10101015 Software Meetings / events
23 Nov 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies Announces New Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 With a Focus on Stage 1 Lung Cancer Characterization 10101015 Software Meetings / events
08 Nov 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2021 10101015 Software Legal
08 Nov 2021
17:45 CET 		MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 octobre 2021 10101015 Software Legal
21 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies Reports on Its 2021 Half-Year Results and Its Q3 2021 Business Activity Indicators 10101015 Software Income
21 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies communique ses résultats semestriels 2021 et son niveau d’activité pour le troisième trimestre 2021 10101015 Software Income
13 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies to Host a Live Webcast and Provide a Company Update on October 25th, 2021 10101015 Software Meetings / events
13 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies fera un point d’avancement par webcast le 25 octobre 2021 10101015 Software Meetings / events
06 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2021 10101015 Software Corporate life
06 Oct 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2021 10101015 Software Corporate life
16 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications 10101015 Software News contracts
16 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies a été confirmé comme fournisseur privilégié d’un des laboratoires pharmaceutiques membre du Top 3 au niveau mondial 10101015 Software News contracts
14 Sep 2021
08:30 CEST 		MEDIAN TECHNOLOGIES Median Technologies modifie la date de publication de ses résultats semestriels 10101015 Software Meetings / events
14 Sep 2021
08:30 CEST 		MEDIAN TECHNOLOGIES Median Technologies Changes the Publication Date of Its H1 2021 Results 10101015 Software Meetings / events
08 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 août 2021 10101015 Software Corporate life
08 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2021 10101015 Software Corporate life
06 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies annonce des performances exceptionnelles pour le diagnostic iBiopsy® (CADx1), permettant de caractériser les nodules pulmonaires malins et bénins dans le cadre d’un dépistage du cancer du poumon 10101015 Software New
06 Sep 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies Announces Outstanding Performance for its iBiopsy® Lung Cancer Screening CADx1 to Accurately Characterize Malignant vs Benign Lung Nodules Based on a Large-scale Patient Cohort 10101015 Software New
05 Aug 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2021 10101015 Software Other subject
05 Aug 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 juillet 2021 10101015 Software Other subject
29 Jul 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies Appoints Jean-Christophe Montigny as Chief Financial Officer and Member of the Executive Committee 10101015 Software Journal / appointments
29 Jul 2021
17:45 CEST 		MEDIAN TECHNOLOGIES Median Technologies nomme Jean-Christophe Montigny en tant que Chief Financial Officer et membre du comité exécutif 10101015 Software Journal / appointments